O N THE
P HARMACEUTICAL
I NDUSTRY
MIT Sloan School of Management
Cambridge, Massachusetts
|
P ROGRAM
O N THE P HARMACEUTICAL I NDUSTRY MIT Sloan School of Management Cambridge, Massachusetts |
|
|
Charles
L. Cooney, Ph.D.
Professor of Chemistry & Biochemical Engineering
Chemical Engineering
Stan
N. Finkelstein, M.D.
Senior Research Scientist
Sloan School of Management
Anthony J.
Sinskey, Sc.D.
Professor of Microbiology
Department of Biology
Stephen C. Chappell, Esq.
CEO, Trimark Research Inc.
Robert Levy, M.D.
Pres., Wyeth-Ayerst
Judy C. Lewent
Sr. VP and CFO, Merck and Company, Inc.
Daniel Roos,
Ph.D.
Japan Steel Industry Prof. of Engineering, MIT
Phillip A. Sharp,
Ph.D.
Salvador E. Luria Prof. of Biology, MIT
Frederick W. Telling, Ph.D.
VP, Corp. Planning & Policy, Pfizer, Inc.
Henri Termeer
Chairman, CEO, Pres., Genzyme Corp.
W. Leigh Thomspon, M.D., Ph.D.
Clinical Pharmacologist
Kathryn Zoon
U.S. Food & Drug Administration
Ernst R.
Berndt
Louis B. Seley Professor of Applied Economics
Economics, Finance, Accounting (EFA)
Rebecca
M. Henderson
Eastman Kodak LFM Professor of Management
Behavioral Policy Science (BPS)
Ralph Katz
Principal Research Associate
Behavioral Policy Science (BPS)
Stewart C.
Myers
Gordon Y Billard Professor of Finance
Economics, Finance, Accounting (EFA)
G. K.
Raju, Ph.D.
Research Affiliate
Pharmaceutical Manufacturing Initiative
(PHARMI)
Scott Stern
Mitsubishi Career Development
Assistant Professor
Behavioral Policy Science (BPS)
Glen L. Urban
Dai-Ichi Kangyo Bank Prof. of Management
Dean Emeritus;
Co-Director of Center for eBusiness@MIT
Lawrence
M. Wein
Digital Equipment Corporate
Leaders for Manufacturing
Professor of Management
Management Science (MS)
Philip Lessard
Instructor in Microbial Genetics
Research Scientist
Biology
ChoKyun Rha
Prof., Biomaterials Science & Engineering Lab
Robert H. Rubin, M.D.
Gordon & Marjorie Osborne Associate Professor
Harvard MIT Div. Health Sciences & Technology
Peter Temin
Elisha Gray H II Professor of Economics
Daniel I.C. Wang
Institute Professor
Director, Biotechnology Process Engineering Center
Richard J.
Wurtman
Cecil H. Green Distinguished Professor of Neurosciences
Stephen R. Byrn
Jordan Prof. of Medicinal Chem., Purdue Univ.
Iain M. Cockburn
Professor of Finance & Economics, Boston University
Steven Garber
Sr. Economist, Rand Corporation
Susan Gates
Sr. Economist, Rand Corporation
Zvi Griliches
Paul M. Warburg Prof. of Econ., Harvard Univ.
Mark Moore
Asst. Prof., Univ. of California, Irvine
Alvin Silk
Prof. of Marketing, Harvard Business School
Manuel Trajtenberg
Prof. of Economics, Tel Aviv Univ.
Albert Williams
Sr. Economist, Rand Corporation
Cathy Carroll
Hoechst Marion Roussel
Douglas Cocks
Eli Lilly & Company
Michael Doodson
Merck & Company, Inc.
Morris Friedman
Merck & Company, Inc.
Paul E. Greenberg
Analysis Group Economics, Inc.
Keith Heithoff
Schering Plough
Timothy Hunt
Pharmacia and Upjohn
Alison Keith
Pfizer
Martin B. Keller, D.M.D.
Brown University
Thomas Kroghan
Eli Lilly & Company, Inc.
Robert Miceli
Pfizer
James M. Russell, M.D.
Univ. of Texas Medical Branch
Program on the Pharmaceutical Industry
MIT Sloan School of Management
38 Memorial Drive, E56-390
Cambridge, MA 02139-4307
telephone: 617-253-5194; fax: 617-253-3033
email: popi-www@mit.edu
For more information, comments, or suggestions contact
popi-www@mit.edu
 |
MIT
Sloan School of Management |